Analysis of Announcement and Current Status of Revision of Drug Instructions of Chinese Traditional Patent Medicine in China from Mar. 2010 to Sept. 2019
ZHANG Lina, TANG Yonghe, HE Jun, et al. Analysis of Announcement and Current Status of Revision of Drug Instructions of Chinese Traditional Patent Medicine in China from Mar. 2010 to Sept. 2019[J]. 2021,21(3):374-376.
ZHANG Lina, TANG Yonghe, HE Jun, et al. Analysis of Announcement and Current Status of Revision of Drug Instructions of Chinese Traditional Patent Medicine in China from Mar. 2010 to Sept. 2019[J]. 2021,21(3):374-376. DOI: 10.14009/j.issn.1672-2124.2021.03.027.
OBJECTIVE: To probe into the current status of revision of drug instructions of Chinese traditional patent medicine in China
so as to promote the standardization and rationalization of Chinese traditional patent medicine.METHODS: Relevant laws and regulations of drug instructions in China were reviewed.The announcement on drug instructions of Chinese traditional patent medicine in China published on the website of the State Drug Administration from Mar.2010 to Sept.2019 were collected.Related data of varieties and revision items of Chinese traditional patent medicine were analyzed
and the existing problems in revision of drug instructions of Chinese traditional patent medicine were summarized.RESULTS: In the past 10 years
the State Drug Administration had issued a total of 83 announcements and notices for the revision of drug instructions of Chinese traditional patent medicine
there were 167 varieties of Chinese traditional patent medicine
including 66 kinds of prescription drugs and 101 kinds of over-the-counter drugs.The revision items were mainly taboos
cautions
adverse drug reactions and warning words.However
through daily practice
it was found that there were still some problems in drug instructions of Chinese traditional patent medicine
such as non-standard writing
poor implementation
insufficient supervision and weak binding force of relevant laws and regulations
which had severe impacts on the safety of medication for patients.CONCLUSIONS: The revision of drug instructions of Chinese traditional patent medicine in China still has problems such as missing contents
which need to be further improved.
关键词
中成药药品说明书修订公告分析
Keywords
Chinese traditional patent medicineDrug instructionsAnnouncement of revisionAnalysis